![]() |
市場調查報告書
商品編碼
1664820
超音波手術刀市場機會、成長動力、產業趨勢分析與 2025 - 2034 年預測Ultrasonic Scalpel Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球超音波手術刀市場價值為 27 億美元,預計 2025 年至 2034 年期間將以 6.9% 的強勁複合年成長率成長。
推動市場擴張的關鍵因素是全球向微創手術 (MIS) 的轉變,微創手術正在成為現代醫療保健的黃金標準。這些手術,包括腹腔鏡手術,具有顯著的優勢,例如恢復時間短、風險小、患者治療效果好。超音波手術刀已成為這些手術中不可或缺的工具,在組織切割和凝固方面提供無與倫比的精確度,對於最佳效果至關重要。此外,門診手術中心的激增也增加了對超音波手術刀等緊湊高效工具的需求,這些工具專為需要快速週轉的大容量環境而設計。
市場範圍 | |
---|---|
起始年份 | 2024 |
預測年份 | 2025-2034 |
起始值 | 27億美元 |
預測值 | 53億美元 |
複合年成長率 | 6.9% |
市場按產品類型細分,包括手持設備、發電機和配件。其中,手持式超音波手術刀的收入最高,到2024年將達到13億美元。它們的人體工學設計和高性能使其對於現代外科手術實踐至關重要。隨著 MIS 在全球範圍內持續受到關注,對這些先進工具的需求預計將穩步上升。
在應用方面,市場涵蓋一般外科、骨科外科、眼科外科、泌尿外科、婦科外科等類別。普通外科手術佔據最大的市場佔有率,2024 年創造了 9.624 億美元的收入。
從區域來看,北美佔據超音波手術刀市場主導地位,到 2024 年將達到 12 億美元,預測期內預計複合年成長率為 6.2%。該地區的成長是由慢性疾病盛行率的上升和人口老化所推動的,這兩者共同增加了對外科手術的需求。用於解決與年齡相關的健康問題的先進手術工具的需求不斷成長,這繼續推動市場擴張,使北美成為主要的成長貢獻者。
隨著技術進步和對微創手術的日益青睞推動需求,超音波手術刀市場有望大幅成長。這一趨勢強調了超音波手術刀在塑造現代外科手術實踐的未來方面發揮的關鍵作用,提供精確度、效率和更好的患者治療效果。
The Global Ultrasonic Scalpel Market was valued at USD 2.7 billion in 2024 and is projected to expand at a robust CAGR of 6.9% from 2025 to 2034. This remarkable growth is fueled by rising demand for outpatient procedures, an increasing volume of gynecological and cardiovascular surgeries, and the growing adoption of robotic-assisted surgical techniques.
A key driver of this market expansion is the global shift toward minimally invasive surgeries (MIS), which are becoming the gold standard in modern healthcare. These procedures, including laparoscopic surgeries, offer significant advantages such as reduced recovery times, minimal risks, and improved patient outcomes. Ultrasonic scalpels have emerged as indispensable tools for these surgeries, offering unparalleled precision in tissue cutting and coagulation, essential for achieving optimal results. Moreover, the surge in outpatient surgical centers has amplified the demand for compact and efficient tools like ultrasonic scalpels, which are tailored for high-volume environments requiring quick turnarounds.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $2.7 Billion |
Forecast Value | $5.3 Billion |
CAGR | 6.9% |
The market is segmented by product type, including handheld devices, generators, and accessories. Among these, handheld ultrasonic scalpels generated the highest revenue, reaching USD 1.3 billion in 2024. These devices are highly favored by surgeons for their precision and control, especially in confined spaces during minimally invasive surgeries. Their ergonomic design and high-performance capabilities make them vital for modern surgical practices. As MIS continues to gain traction globally, the demand for these advanced tools is expected to rise steadily.
In terms of application, the market spans categories such as general surgery, orthopedic surgery, ophthalmic surgery, urological surgery, gynecological surgery, and others. General surgery accounted for the largest market share, generating USD 962.4 million in revenue in 2024. This segment encompasses a wide range of essential procedures where ultrasonic scalpels play a critical role in ensuring precision and effectiveness, making them indispensable in achieving successful surgical outcomes.
Regionally, North America dominated the ultrasonic scalpel market, reaching USD 1.2 billion in 2024, with a projected CAGR of 6.2% during the forecast period. The region's growth is driven by the increasing prevalence of chronic health conditions and an aging population, which together amplify the demand for surgical interventions. The rising need for advanced surgical tools to address age-related health issues continues to bolster market expansion, positioning North America as a key growth contributor.
The ultrasonic scalpel market is poised for substantial growth as technological advancements and the rising preference for minimally invasive procedures drive demand. This trend underscores the critical role of ultrasonic scalpels in shaping the future of modern surgical practices, offering precision, efficiency, and enhanced patient outcomes.